Get the latest news, advances in research, policy work, and education program updates from HAI in your inbox weekly.
Sign Up For Latest News
This talk will cover key insights from the third AI100 report, AI Goes Mainstream: The Scaling Era and the Rise of Generative AI, set for release in November 2026. The report was commissioned by the AI100 standing committee and led by study panel chair Michael Wooldridge.

This talk will cover key insights from the third AI100 report, AI Goes Mainstream: The Scaling Era and the Rise of Generative AI, set for release in November 2026. The report was commissioned by the AI100 standing committee and led by study panel chair Michael Wooldridge.
Sessions run Wednesdays from 4:30–5:30 PM in CoDa E160. Each session features a different Stanford speaker; talk titles are announced by the organizers.

Sessions run Wednesdays from 4:30–5:30 PM in CoDa E160. Each session features a different Stanford speaker; talk titles are announced by the organizers.
This talk will explore the latest advances in computational protein design and structure prediction, highlighting NVIDIA technologies such as cuEquivariance and the Proteína family of models, including the latest RFdiffusion4 (RFD4)–Proteína developments. We will discuss how accelerated geometric deep learning and generative AI are enabling scalable, high-performance protein modeling and the design of novel proteins with tailored structures and functions.
Bio:
Youssef Nashed is a Senior Solutions Architect on NVIDIA's Healthcare and Life Sciences team. He joined NVIDIA from Bristol Myers Squibb (BMS), where he was a Senior Principal Scientist focused on machine learning and computational protein design. At BMS, Youssef led a team developing and deploying AI models for antibody discovery and development. He previously served as an Assistant Professor at Northwestern University and conducted research in structural biology at SLAC National Accelerator Laboratory at Stanford. Youssef began his career in high-performance and large-scale GPU computing at Argonne National Laboratory. His background spans computer science, mathematics, structural biology, and AI-driven protein engineering.
Location: CoDa W401

This talk will explore the latest advances in computational protein design and structure prediction, highlighting NVIDIA technologies such as cuEquivariance and the Proteína family of models, including the latest RFdiffusion4 (RFD4)–Proteína developments. We will discuss how accelerated geometric deep learning and generative AI are enabling scalable, high-performance protein modeling and the design of novel proteins with tailored structures and functions.
Bio:
Youssef Nashed is a Senior Solutions Architect on NVIDIA's Healthcare and Life Sciences team. He joined NVIDIA from Bristol Myers Squibb (BMS), where he was a Senior Principal Scientist focused on machine learning and computational protein design. At BMS, Youssef led a team developing and deploying AI models for antibody discovery and development. He previously served as an Assistant Professor at Northwestern University and conducted research in structural biology at SLAC National Accelerator Laboratory at Stanford. Youssef began his career in high-performance and large-scale GPU computing at Argonne National Laboratory. His background spans computer science, mathematics, structural biology, and AI-driven protein engineering.
Location: CoDa W401
Dr. Danny Huang is a neurosurgery resident and post-doctorate researcher in the Department of Neurosurgery at Stanford University. As a physician-scientist with a focus on signal processing and neural electrophysiology, he is interested in building network-based brain computer interface (BCI) for neuropsychiatric disorders. He received his BSc at University of Alberta and his MD at Stanford University.
Deep Brain Stimulation (DBS) for chronic pain remains an off-label intervention with suboptimal outcomes, currently limited by a "one-size-fits-all" approach and approximately 50% efficacy. This talk proposes a transition from empirical, open-loop stimulation to a platform for adaptive, circuit-modifying neuromodulation built on three scientific pillars. First, we address the challenge of precision targeting by defining therapeutic circuits. We present a rapid, scalable stereoelectroencephalography (sEEG) mapping protocol that identifies components of the human thalamocortical circuit that rapidly alleviated intractable chronic facial pain. Second, we discuss the development of multimodal biomarkers for closed-loop control. Using a deep learning approach, we demonstrate that pain states can be decoded from a combination of intracranial neural features and automated facial dynamics, providing an objective surrogate for subjective pain reporting. Finally, we explore moving beyond symptom suppression toward disease modification. We present evidence that theta-burst direct electrical stimulation can induce lasting remodeling of human brain networks. By designing spatially and temporally selective stimulation patterns, we aim to reverse maladaptive circuit changes and drive network reorganization. By integrating these computational tools directly into the functional neurosurgical workflow, we move closer to a personalized, "biologically informed" treatment for intractable brain disorders.
Seminars attendees are invited to stay for a happy hour reception after the seminar to continue the conversation with the speaker.
For additional information and upcoming events, please visit the seminar series page
Stay updated on groundbreaking insights from the Center for Neural Data Science by subscribing to the Center's listserv! Click here to subscribe: neural-data-science@lists.stanford.edu